ATROPEN Drug Patent Profile
✉ Email this page to a colleague
When do Atropen patents expire, and what generic alternatives are available?
Atropen is a drug marketed by MMT and is included in one NDA.
The generic ingredient in ATROPEN is atropine. There are twenty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the atropine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATROPEN?
- What are the global sales for ATROPEN?
- What is Average Wholesale Price for ATROPEN?
Summary for ATROPEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 3 |
| Patent Applications: | 3,664 |
| DailyMed Link: | ATROPEN at DailyMed |
Recent Clinical Trials for ATROPEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Manitoba | Phase 4 |
| Craig J. Huang | N/A |
| MicroDose Defense Products L.L.C. | Phase 1 |
Pharmacology for ATROPEN
| Drug Class | Anticholinergic Cholinergic Muscarinic Antagonist |
| Mechanism of Action | Cholinergic Antagonists Cholinergic Muscarinic Antagonists |
US Patents and Regulatory Information for ATROPEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mmt | ATROPEN | atropine | SOLUTION;INTRAMUSCULAR | 017106-004 | Sep 17, 2004 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mmt | ATROPEN | atropine | SOLUTION;INTRAMUSCULAR | 017106-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mmt | ATROPEN | atropine | SOLUTION;INTRAMUSCULAR | 017106-003 | Jun 19, 2003 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
